Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.
Position
The Senior Director of Drug Safety and Toxicology will lead the safety assessment function at Eikon Therapeutics. This position will provide technical and scientific leadership to the strategy and execution of safety studies from late pre-clinical, IND enabling, through to registration. The individual will interface with internal discovery and clinical project teams as well as contract research organizations (CROs) for non-GLP and GLP work. In addition, this individual would be responsible for the authoring of regulatory documents throughout development and interactions with regulatory agencies.
About You
You are a drug safety expert who has a deep understanding of safety assessment requirements across the stages of pre-clinical and clinical development and has experience in small molecules and biologics (a plus) in multiple therapeutic areas including oncology and non-oncology. You’re a hands-on leader who thrives in a fast-paced, dynamic environment. You’re well-organized, detail oriented, and take pride in your ability to rapidly analyze situations and make judicious decisions. You’re collaborative by nature with uncompromising integrity.
What You’ll Do
Qualifications
At Eikon, employee compensation also includes bonus and equity compensation, in addition to several generous benefit programs, including:
The expected salary range for this role is $248,000 to $270,750 depending on skills, competency, and the market demand for your expertise.
Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment.
We are currently not accepting any new third-party agencies or firms at this time. Please do not forward unsolicited agency resumes to our website, employees or Human Resources. Eikon Therapeutics will not pay fees to any third-party agency or firm associated with unsolicited resumes.